About
4
Publications
393
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
13
Citations
Citations since 2017
Introduction
Ivan Kmezic currently works at the Department of Neurology, Karolinska University Hospital. Ivan does research in Neurology. His most recent publication is "Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies".
Additional affiliations
September 2014 - present
Publications
Publications (4)
Importance
Rituximab is a third-line option for refractory generalized myasthenia gravis (MG) based on empirical evidence, but its effect in new-onset disease is unknown.
Objective
To investigate the efficacy and safety of rituximab compared with placebo as an add-on to standard of care for MG.
Design, Setting, and Participants
This randomized, d...
Background and purpose:
To investigate the diagnostic and prognostic value of axonal injury biomarkers in patients with inflammatory polyneuropathies.
Methods:
Neurofilament light (NfL) chain and total tau (T-tau) were measured in the CSF and plasma in 41 patients with Guillain-Barré syndrome (GBS), 32 patients with chronic inflammatory demyelin...
Background:
Laboratory tests to assist in the diagnosis and monitoring of neuroinflammatory diseases are scarce. The soluble form of the CD27 molecule (sCD27) is shed in high concentrations by activated T cells and can be detected in the cerebrospinal fluid. The aim of this study was to investigate whether CSF quantitation of sCD27 could discrimin...
Background
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disorder of the central nervous system caused by reactivation of the JC-virus and is in most cases associated with underlying immunosuppression. Acquired immune deficiency syndrome (AIDS) and hematological malignancies are well-known predisposing factors for PML. However...
